Основная статистика
| CIK | 1139463 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Medcath Corp
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| March 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* MedCath Corp ** (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 ** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 12, 2020 |
MDTH / Medcath Corp / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MEDCATH CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| February 9, 2018 |
MDTH / Medcath Corp / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment SC 13G/A 1 dfs699.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* MEDCATH CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 9, 2017 |
MDTH / Medcath Corp / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* MEDCATH CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 9, 2016 |
MDTH / Medcath Corp / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* MEDCATH CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 5, 2015 |
MDTH / Medcath Corp / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7)* MEDCATH CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 14, 2014 |
MDTH / Medcath Corp / PAR INVESTMENT PARTNERS LP - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Medcath Corporation (Name of Issuer) Common stock, par value $.01 (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| February 10, 2014 |
MDTH / Medcath Corp / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* MEDCATH CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 11, 2013 |
MDTH / Medcath Corp / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* MEDCATH CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| December 14, 2012 |
List of Subsidiaries EXHIBIT 21.1 MEDCATH CORPORATION SUBSIDIARIES Name Jurisdiction of Organization/Incorporation Austin MOB, Inc. North Carolina Central Park Medical Office Building, LP Texas Center for Cardiac Sleep Medicine, LLC North Carolina HHSA, LP Texas MedCath Incorporated North Carolina San Antonio Hospital Management, Inc. North Carolina San Antonio Holdings, Inc. Arizona Sun City Card |
|
| December 14, 2012 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2012 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-33009 MedCath Corporation (Exact name of registrant as specified in its charter) Delaware 56-2248952 (State or other jurisdiction of incorporation or organization) (I. |
|
| December 14, 2012 |
FIRST AMENDMENT TO EMPLOYMENT, CONFIDENTIALITY AND NON-COMPETE First Amendment to Employment, Confidentiality and Non-Compete Agreement Exhibit 10. |
|
| December 14, 2012 |
Certificate of Dissolution of Medcath Corporation Exhibit 3.4 CERTIFICATE OF DISSOLUTION OF MEDCATH CORPORATION Pursuant to Section 275(a) and (b) of the General Corporation Law of the State of Delaware MedCath Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY: 1. The name of the Co |
|
| October 29, 2012 |
Exhibit 99.1 MEDCATH CONTACTS: Art Parker Lora Ramsey President & Chief Executive Officer Chief Financial Officer (704) 815-7700 (704) 815-7700 MEDCATH ANNOUNCES FILING OF CERTIFICATION ON FORM 15 TO SUSPEND ITS REPORTING OBLIGATIONS UNDER SECTION 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 CHARLOTTE, N.C., October 29, 2012—MedCath Corporation (the “Company”) announced today that it intends to fi |
|
| October 29, 2012 |
FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-33009 MedCath Corporation (Exact name of registrant as specified |
|
| October 29, 2012 |
Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
|
| October 22, 2012 |
- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 Registration No. 333-141267 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedCath Corporation (Exact name of Registrant as specified in its Charter) Delaware 56-2248952 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 10720 |
|
| September 21, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
|
| September 21, 2012 |
EX-99.1 2 d414822dex991.htm PRESS RELEASE Exhibit 99.1 MEDCATH CONTACTS: Art Parker Lora Ramsey President & Chief Executive Officer Chief Financial Officer (704) 815-7700 (704) 815-7700 MEDCATH ANNOUNCES FILING OF CERTIFICATE OF DISSOLUTION; DELISTING FROM NASDAQ CHARLOTTE, N.C., September 21, 2012—MedCath Corporation (Nasdaq: MDTH) announced today that the Company has filed a certificate of disso |
|
| September 19, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
|
| September 13, 2012 |
Registration No. 333-137756 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedCath Corporation (Exact name of Registrant as specified in its Charter) Delaware 56-2248952 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 10720 |
|
| September 10, 2012 |
S-8 Registration No. 333-82432 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedCath Corporation (Exact name of Registrant as specified in its Charter) Delaware 56-2248952 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 107 |
|
| September 10, 2012 |
Form S-8 Registration No. 333-132234 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedCath Corporation (Exact name of Registrant as specified in its Charter) Delaware 56-2248952 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No |
|
| September 10, 2012 |
Form 8-A12B/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A/A Amendment No. 1 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 MedCath Corporation (Exact name of registrant as specified in charter) Delaware 56-2248952 (State of incorporation or organization) (IRS Employer Identification No |
|
| September 10, 2012 |
S-8 POS Registration No. 333-151579 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedCath Corporation (Exact name of Registrant as specified in its Charter) Delaware 56-2248952 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No. |
|
| September 10, 2012 |
Form S-8 Registration No. 333-82430 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedCath Corporation (Exact name of Registrant as specified in its Charter) Delaware 56-2248952 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No. |
|
| September 10, 2012 |
AMENDMENT NO. 1 RIGHTS AGREEMENT Amendment No. 1, dated as of August 28, 2012, to Rights Agreement Exhibit 4.1 AMENDMENT NO. 1 TO RIGHTS AGREEMENT AMENDMENT NO. 1 to RIGHTS AGREEMENT (this “Amendment”) between MedCath Corporation, a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC as rights agent (the “Rights Agent”) is effective this 28th day of August, 2012. WHEREAS, the Company and the Rig |
|
| September 6, 2012 |
Quarterly Report - FORM 10-Q AMENDMENT NO. 1 Form 10-Q Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2012 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-33009 ME |
|
| August 28, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
|
| August 28, 2012 |
Press Release Exhibit 99.1 MEDCATH CONTACTS: Art Parker Lora Ramsey President & Chief Executive Officer Chief Financial Officer (704) 815-7700 (704) 815-7700 MEDCATH ANNOUNCES PRE-FILING LIQUIDATING DISTRIBUTION OF $6.33 PER SHARE; SETS DATE FOR FILING CERTIFICATE OF DISSOLUTION CHARLOTTE, N.C., Aug. 28, 2012 – MedCath Corporation (Nasdaq: MDTH) announced that the Company’s Board of Directors toda |
|
| August 28, 2012 |
AMENDMENT NO. 1 RIGHTS AGREEMENT Amendment No. 1 to Rights Agreement Exhibit 4.1 AMENDMENT NO. 1 TO RIGHTS AGREEMENT AMENDMENT NO. 1 to RIGHTS AGREEMENT (this “Amendment”) between MedCath Corporation, a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC as rights agent (the “Rights Agent”) is effective this 28th day of August, 2012. WHEREAS, the Company and the Rights Agent are parties to a Rig |
|
| August 9, 2012 |
Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
|
| July 6, 2012 |
Debt and Equity Purchase Agreement Exhibit 2.1 DEBT AND EQUITY PURCHASE AGREEMENT BY AND AMONG CCG OF CALIFORNIA, LLC, HHBF, INC. AND MEDCATH FINANCE COMPANY, LLC Dated as of June 30, 2012 Table of Contents ARTICLE I DEFINITIONS 1 1.1 Definitions 1 1.2 Interpretation 11 1.3 Schedules 12 ARTICLE II SALE AND PURCHASE 12 2.1 Transfer of Equity Interest 12 2.2 Transfer of Finco Obligations 12 2.3 Purc |
|
| July 6, 2012 |
Net Asset Value as of March 31, 2012 Exhibit 99.1 (in thousands except per share data) Current Estimated Pre-Filing Distribution Low End High End Net Asset Value as of March 31, 2012 (1 ) $ 193,584 $ 193,584 Cash Holdback (2 ) (58,000 ) (48,000 ) Non-cash Assets as of Distribution Date (3 ) (18,500 ) (18,400 ) Total Estimated Net Assets Available for Distribution (4 ) $ 117,084 $ 127,184 Estimated Pre-Filing Distribution Per Share $ |
|
| July 6, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
|
| May 10, 2012 |
Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
|
| February 14, 2012 |
MDTH / Medcath Corp / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* MEDCATH CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 14, 2012 |
MDTH / Medcath Corp / WS CAPITAL LLC - MEDA13GAM2123111 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* MEDCATH CORPORATION (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 58404W109 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| February 9, 2012 |
FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
|
| February 2, 2012 |
MDTH / Medcath Corp / OSKIE CAPITAL MANAGEMENT, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| January 31, 2012 |
Form 10-K/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 30, 2012 |
Form 10-K/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 10, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 9, 2012 MEDCATH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35208 56-2248952 (State or other jurisdiction of incorporation) (Commi |
